The trajectory of companies tied to flagship drugs like Viagra presents a nuanced investment landscape . While the initial boom of copyright, fueled by Viagra's extraordinary popularity, generated substantial profits , the patent expiration in key territories has introduced significant volatility. Investors are now assessing the impact of lower-cos